Japanese Journal of Clinical Immunology
Online ISSN : 1349-7413
Print ISSN : 0911-4300
ISSN-L : 0911-4300
Relapsing polychondritis developing in a patient with Graves' disease: A possible association with propylthiouracil
Naoko OhyaYasuo SuzukiYoichi IchikawaKunihiko Ito
Author information
JOURNAL FREE ACCESS

1999 Volume 22 Issue 1 Pages 30-36

Details
Abstract
A 31-year-old woman presented 1993 with fever, painful swelling of cartilaginous portions of the ears and the bridge of nose, polyarthralgia including costochondroral pains, and episcleritis. She has been taking propylthiouracil since 1991 when she was diagnosed as Graves' disease. Laboratory evaluations revealed an elevated erythrocyte sedimentation rate (ESR) of 133mm/h, a high CRP level of 13.2mg/dl and positive antinuclear antibodies and anti-type II collagen antibodies. Histopathological findings of the biopsy specimen from the auricular cartilage included chondrocyte degeneration, matrix destruction and inflammatory cell infiltration. She was diagnosed as RP and treatment with 30mg/day of prednisolone dramatically improved all symptoms and signs, accompanied by a fall in ESR, CRP and autoantibodies. When prednisolone was tapered to 5mg/day, a clinical relapse occurred. After discontinuation of propylthiouracil, she has been well without prednisolone.
Propylthiouracil-induced SLE-like syndrome or antineutrophil cytoplasmic antibodies (ANCA) related angitis has been reported previously. In addition, recent studies demonstrated that about 20% of sera from patients with relapsing polychondritis are P-ANCA positive. This is the first report suggesting a possible association between the development of relapsing polychondritis and propylthiouracil.
Content from these authors
© The Japan Society for Clinical Immunology
Previous article Next article
feedback
Top